Skip to main content
TipRanks
Go Ultimate75% OFF

4D Molecular Therapeutics (FDMT) Balance Sheet

534 Followers

4D Molecular Therapeutics Balance Sheet

4D Molecular Therapeutics's total assets for Q2 2026 were $492.62M, a decrease of 3.96% from the previous quarter. FDMT total liabilities were $84.96M for the fiscal quarter, a 39.11% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 566.71M$ 560.38M$ 339.89M$ 261.85M$ 353.49M
$ 61.05M$ 49.78M$ 32.06M$ 30.51M$ 34.38M
$ 505.66M$ 510.61M$ 307.83M$ 231.34M$ 319.11M

Currency in USD

4D Molecular Therapeutics Liabilities to Assets

0200M400M600M0 %80 %160 %240 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets